NEPHROPLUS logo

Nephrocare Health SERV L

NEPHROPLUS·NSE·
686.45 -3.15 (-0.46%)
Market Cap6892.82 Cr
PE Ratio89.61
Volume69,840
Day High - Low695.00 - 677.60
52W High-Low769.75 - 446.00
DocStoX Score
5.4/10
Weak
Fair Value
Sign in to see
ROE
9.06%
Average
P/E
89.61x
Expensive
Debt / Equity
0.01
Low
Industry
Healthcare
Healthcare Service Provider
Overall View
Mixed

Price performance

Day677.60
695.00
52W446.00
769.75
DocStoX take

Supported by growth (9.8) and momentum (7.5), but held back by valuation (0.0). Growth looks strong at 9.8, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.4
/10
Weak
Quality
Modest
ROE 9.1%
Valuation
Expensive
P/E 89.6×
Growth
Strong
Revenue +28.4% 5Y CAGR
Risk
Moderate
D/E 0.01
Momentum
Strong
74% of 52-week range

At a glance

Market Cap
₹6,893 Cr
52W High / Low
₹770 / ₹446
Dividend Yield
0.00%
Promoter Holding
63.85%
EPS (TTM)
₹7.66
Book Value
₹111.00

Key highlights

  • Profit compounding 138% a year
  • Low leverage — D/E 0.01
  • Revenue compounding 28% a year
  • Loss-making in some of the last 5 years
  • Valuation is weak (0.0/10)
3 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Healthcare Service Provider

NEPHROCARE HEALTH SERV L peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.